Salarius Pharmaceuticals, Inc. — Director's Dealing 2019

Jul 24, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Salarius Pharmaceuticals, Inc. (SLRX)
CIK: 0001615219
Period of Report: 2019-07-19

Reporting Person: Lammers Paul (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6974	Direct

Footnotes

F1: Received in connection with the Issuer's business combination (the "Merger") with Salarius Pharmaceuticals, LLC ("Private Salarius") in accordance with the terms of the Agreement and Plan of Merger dated as of January 3, 2019 and amended on June 27, 2019, by and among Issuer, Falcon Acquisition Sub, LLC and Private Salarius, in exchange for 6,974 shares of common stock of Private Salarius.